Research Study

Astragaloside IV ameliorates cognitive impairment and protects oligodendrocytes from antioxidative stress via regulation of the SIRT1/Nrf2 signaling pathway.

📅 2023 🔗 DOI: 10.1016/j.neuint.2023.105535
Citation
Ma J., Chen T., Wang R. (2023). Astragaloside IV ameliorates cognitive impairment and protects oligodendrocytes from antioxidative stress via regulation of the SIRT1/Nrf2 signaling pathway.. Neurochem Int. DOI: 10.1016/j.neuint.2023.105535
View Full Study →

Abstract

Abstract not available. See citation for source.

Related Substances

Astragaloside Iv
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.